Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic resonance feasibility study

Table 4 Pericardial fat volume and risk factors

	All	HIV (+)	HIV (-)
	r (p value)	r (p value)	r (p value)
BMI	0.71***	0.58***	0.79***
Waist circumference	0.73***	0.65**	0.77***
Hip circumference	0.39**	0.24 (0.23)	0.63**
Waist/hip ratio	0.70 ***	0.71**	0.60**
Family history	0.06 (0.67)	0.3 (0.13)	0.33 (0.14)
Current smoking	0.16 (0.27)	0.01 (0.94)	0.29 (0.18)
Prior smoking	0.23 (0.11)	0.1 (0.62)	0.25 (0.26)
Level of exercise	0.23 (0.1)	0.08 (0.68)	0.36 (0.09)
Total cholesterol	0.24 (0.1)	0.19 (0.36)	0.35 (0.12)
LDL cholesterol	0.23 (0.12)	0.10 (0.61)	0.33 (0.15)
Triglycerides	0.39**	0.40 (0.051)	0.64**
Fasting glucose	0.10 (0.49)	0.04 (0.82)	0.05 (0.8)
Risk factors for metabolic syndrome	0.48**	0.34 (0.09)	0.58**
Framingham risk score	0.53**	0.41*	0.77***

Correlation Coefficients between pericardial fat volume at the level of LM origin and risk factors in all population, HIV (+) subjects and HIV (-) controls
BMI body mass index, LDL low-density lipoprotein
*p < 0.05
**p < 0.01
***p < 0.0001

ISSN: 1532-429X